Senior Medical Leader
Johnson & Johnson
Sarah Nagle is a Senior Medical Leader at Johnson & Johnson Innovative Medicine and currently serves as the Study Responsible Physician for the Phase 3 KLK2-PASenger and KLK2-comPAS studies. She earned her medical degree from Jefferson Medical College and completed her residency and fellowship training at the University of Pennsylvania. Following fellowship, she joined the faculty at the Knight Cancer Institute at Oregon Health & Science University, where she served as Associate Professor of Medicine. Sarah joined Johnson & Johnson in 2022 and has contributed to several key oncology programs, including CARVYKTI, teclistamab, and most recently pasritamig, supporting the clinical development of innovative therapies for patients with cancer.